個股熱度排行 | 11月22日港股盤前
根據uSMART輿情監測數據,從21日晚間到22日港股盤前時間段,市場關注指數最高的3只股票是晨鳴紙業、金斯瑞生物科技、比亞迪股份。
11月22日—港股關注排行TOP3

晨鳴紙業

關注度第一爲晨鳴紙業,該股上個交易日收盤下跌0.82%,報於2.42港元。近5個交易日累計持平。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
晨鳴紙業:擬收購壽光美倫1.19%股權、晨融基金44.44%LP份額及晨融基金0.22%GP份額
晨鳴紙業:爲盤活融資租賃業務資產、子公司擬參設壽光產投
金斯瑞生物科技

關注度第二爲金斯瑞生物科技,該股上個交易日收盤下跌1.77%,報於19.94港元。近5個交易日累計下跌15.69%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
金斯瑞生物科技:FDA已批準傳奇生物新藥臨牀試驗申請 以推進LB2102臨牀開發
金斯瑞生物科技:傳奇生物新藥臨牀試驗申請獲FDA批準 用於治療小細胞肺癌
比亞迪股份

關注度第三爲比亞迪股份,該股上個交易日收盤下跌0.11%,報於184.40港元。近5個交易日累計下跌3.20%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
鬆芝股份:即將量產比亞迪、蔚來等客戶的空調箱項目 按規劃推進儲能電池熱管理產品
比亞迪與摩洛哥經銷商Auto Nejma達成戰略合作
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.